Jaber Firas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jaber Firas has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Jose Maria Polo
University of Adelaide
7 shared publications - Christian Maximilian Nefzger
Department of Anatomy and Developmental Biology, Monash University, Melbourne, Australia
5 shared publications Xiaodong Liu
Department of Anatomy and Developmental Biology, Monash University, Wellington Road, Clayton, VIC 3800, Australia; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Wellington Road, Clayton, VIC 3800, Australia; Australian Regenerative Medicine Institute, Monash University, Wellington Road, Clayton, VIC 3800, Australia
5 shared publications- Anja S. Knaupp
Monash University
4 shared publications - Fernando J. Rossello
Murdoch Children’s Research Institute
3 shared publications Jahnvi Pflueger
Australian Research Council Centre of Excellence in Plant Energy Biology, School of Molecular Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia; Harry Perkins Institute of Medical Research, 6 Verdun Street, Nedlands, WA 6009, Australia
3 shared publications
Latest Publications
- Open Access
- 1 February 2018
- Published by Elsevier in Stem Cell Reports
- Vol. 10 (2) , 331-338
BAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming
- 1 February 2018
- Published by Elsevier in Stem Cell Reports
- Vol. 10 (2) , 331-338
Open AccessBAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming
- 1 December 2017
- Published by Elsevier in Cell Stem Cell
- Vol. 21 (6) , 834-845.e6
Transient and Permanent Reconfiguration of Chromatin and Transcription Factor Occupancy Drive Reprogramming
- 1 December 2017
- Published by Elsevier in Cell Stem Cell
- Vol. 21 (6) , 834-845.e6
Transient and Permanent Reconfiguration of Chromatin and Transcription Factor Occupancy Drive Reprogramming
- Open Access
- 1 December 2017
- Published by Elsevier in Cell Reports
- Vol. 21 (10) , 2649-2660
Cell Type of Origin Dictates the Route to Pluripotency
- 1 December 2017
- Published by Elsevier in Cell Reports
- Vol. 21 (10) , 2649-2660
Open AccessCell Type of Origin Dictates the Route to Pluripotency
- Open Access
- 22 November 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 16001
Specification of murine ground state pluripotent stem cells to regional neuronal populations
Pluripotent stem cells (PSCs) are a valuable tool for interrogating development, disease modelling, drug discovery and transplantation. Despite the burgeoned capability to fate restrict human PSCs to specific neural lineages, comparative protocols for mouse PSCs have not similarly advanced. Mouse protocols fail to recapitulate neural development, consequently yielding highly heterogeneous populations, yet mouse PSCs remain a valuable scientific tool as differentiation is rapid, cost effective and an extensive repertoire of transgenic lines provides an invaluable resource for understanding biology. Here we developed protocols for neural fate restriction of mouse PSCs, using knowledge of embryonic development and recent progress with human equivalents. These methodologies rely upon naïve ground-state PSCs temporarily transitioning through LIF-responsive stage prior to neural induction and rapid exposure to regional morphogens. Neural subtypes generated included those of the dorsal forebrain, ventral forebrain, ventral midbrain and hindbrain. This rapid specification, without feeder layers or embryoid-body formation, resulted in high proportions of correctly specified progenitors and neurons with robust reproducibility. These generated neural progenitors/neurons will provide a valuable resource to further understand development, as well disorders affecting specific neuronal subpopulations.
- 22 November 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 16001
Open AccessSpecification of murine ground state pluripotent stem cells to regional neuronal populations
Pluripotent stem cells (PSCs) are a valuable tool for interrogating development, disease modelling, drug discovery and transplantation. Despite the burgeoned capability to fate restrict human PSCs to specific neural lineages, comparative protocols for mouse PSCs have not similarly advanced. Mouse protocols fail to recapitulate neural development, consequently yielding highly heterogeneous populations, yet mouse PSCs remain a valuable scientific tool as differentiation is rapid, cost effective and an extensive repertoire of transgenic lines provides an invaluable resource for understanding biology. Here we developed protocols for neural fate restriction of mouse PSCs, using knowledge of embryonic development and recent progress with human equivalents. These methodologies rely upon naïve ground-state PSCs temporarily transitioning through LIF-responsive stage prior to neural induction and rapid exposure to regional morphogens. Neural subtypes generated included those of the dorsal forebrain, ventral forebrain, ventral midbrain and hindbrain. This rapid specification, without feeder layers or embryoid-body formation, resulted in high proportions of correctly specified progenitors and neurons with robust reproducibility. These generated neural progenitors/neurons will provide a valuable resource to further understand development, as well disorders affecting specific neuronal subpopulations.
- 25 September 2017
- Published by Springer Nature in Nature Methods
- Vol. 14 (11) , 1055-1062
Comprehensive characterization of distinct states of human naive pluripotency generated by reprogramming
Recent reports on the characteristics of naive human pluripotent stem cells (hPSCs) obtained using independent methods differ. Naive hPSCs have been mainly derived by conversion from primed hPSCs or by direct derivation from human embryos rather than by somatic cell reprogramming. To provide an unbiased molecular and functional reference, we derived genetically matched naive hPSCs by direct reprogramming of fibroblasts and by primed-to-naive conversion using different naive conditions (NHSM, RSeT, 5iLAF and t2iLGöY). Our results show that hPSCs obtained in these different conditions display a spectrum of naive characteristics. Furthermore, our characterization identifies KLF4 as sufficient for conversion of primed hPSCs into naive t2iLGöY hPSCs, underscoring the role that reprogramming factors can play for the derivation of bona fide naive hPSCs.
- 25 September 2017
- Published by Springer Nature in Nature Methods
- Vol. 14 (11) , 1055-1062
Comprehensive characterization of distinct states of human naive pluripotency generated by reprogramming
Recent reports on the characteristics of naive human pluripotent stem cells (hPSCs) obtained using independent methods differ. Naive hPSCs have been mainly derived by conversion from primed hPSCs or by direct derivation from human embryos rather than by somatic cell reprogramming. To provide an unbiased molecular and functional reference, we derived genetically matched naive hPSCs by direct reprogramming of fibroblasts and by primed-to-naive conversion using different naive conditions (NHSM, RSeT, 5iLAF and t2iLGöY). Our results show that hPSCs obtained in these different conditions display a spectrum of naive characteristics. Furthermore, our characterization identifies KLF4 as sufficient for conversion of primed hPSCs into naive t2iLGöY hPSCs, underscoring the role that reprogramming factors can play for the derivation of bona fide naive hPSCs.
- 18 January 2016
- Published by Springer Nature in Nature Genetics
- Vol. 48 (3) , 331-335
A predictive computational framework for direct reprogramming between human cell types
Owen Rackham, Jose Polo, Julian Gough and colleagues present a method, Mogrify, for predicting sets of transcription factors that can induce transdifferentiation between cell types. They show that Mogrify is able to predict known factors for published cell conversions and experimentally validate factors for two new conversions. Transdifferentiation, the process of converting from one cell type to another without going through a pluripotent state, has great promise for regenerative medicine. The identification of key transcription factors for reprogramming is currently limited by the cost of exhaustive experimental testing of plausible sets of factors, an approach that is inefficient and unscalable. Here we present a predictive system (Mogrify) that combines gene expression data with regulatory network information to predict the reprogramming factors necessary to induce cell conversion. We have applied Mogrify to 173 human cell types and 134 tissues, defining an atlas of cellular reprogramming. Mogrify correctly predicts the transcription factors used in known transdifferentiations. Furthermore, we validated two new transdifferentiations predicted by Mogrify. We provide a practical and efficient mechanism for systematically implementing novel cell conversions, facilitating the generalization of reprogramming of human cells. Predictions are made available to help rapidly further the field of cell conversion.
- 18 January 2016
- Published by Springer Nature in Nature Genetics
- Vol. 48 (3) , 331-335
A predictive computational framework for direct reprogramming between human cell types
Owen Rackham, Jose Polo, Julian Gough and colleagues present a method, Mogrify, for predicting sets of transcription factors that can induce transdifferentiation between cell types. They show that Mogrify is able to predict known factors for published cell conversions and experimentally validate factors for two new conversions. Transdifferentiation, the process of converting from one cell type to another without going through a pluripotent state, has great promise for regenerative medicine. The identification of key transcription factors for reprogramming is currently limited by the cost of exhaustive experimental testing of plausible sets of factors, an approach that is inefficient and unscalable. Here we present a predictive system (Mogrify) that combines gene expression data with regulatory network information to predict the reprogramming factors necessary to induce cell conversion. We have applied Mogrify to 173 human cell types and 134 tissues, defining an atlas of cellular reprogramming. Mogrify correctly predicts the transcription factors used in known transdifferentiations. Furthermore, we validated two new transdifferentiations predicted by Mogrify. We provide a practical and efficient mechanism for systematically implementing novel cell conversions, facilitating the generalization of reprogramming of human cells. Predictions are made available to help rapidly further the field of cell conversion.
- 3 February 2015
- Published by Wiley in Immunology & Cell Biology
- Vol. 93 (3) , 284-289
Transcription factor‐mediated reprogramming: epigenetics and therapeutic potential
Cellular reprogramming refers to the conversion of one cell type into another by altering its epigenetic marks. This can be achieved by three different methods: somatic cell nuclear transfer, cell fusion and transcription factor (TF)‐mediated reprogramming. TF‐mediated reprogramming can occur through several means, either reverting backwards to a pluripotent state before redifferentiating to a new cell type (otherwise known as induced pluripotency), by transdifferentiating directly into a new cell type (bypassing the intermediate pluripotent stage), or, by using the induced pluripotency pathway without reaching the pluripotent state. The possibility of reprogramming any cell type of interest not only sheds new insights on cellular plasticity, but also provides a novel use of this technology across several platforms, most notably in cellular replacement therapies, disease modelling and drug screening. This review will focus on the different ways of implementing TF‐mediated reprogramming, their associated epigenetic changes and its therapeutic potential.
- 3 February 2015
- Published by Wiley in Immunology & Cell Biology
- Vol. 93 (3) , 284-289
Transcription factor‐mediated reprogramming: epigenetics and therapeutic potential
Cellular reprogramming refers to the conversion of one cell type into another by altering its epigenetic marks. This can be achieved by three different methods: somatic cell nuclear transfer, cell fusion and transcription factor (TF)‐mediated reprogramming. TF‐mediated reprogramming can occur through several means, either reverting backwards to a pluripotent state before redifferentiating to a new cell type (otherwise known as induced pluripotency), by transdifferentiating directly into a new cell type (bypassing the intermediate pluripotent stage), or, by using the induced pluripotency pathway without reaching the pluripotent state. The possibility of reprogramming any cell type of interest not only sheds new insights on cellular plasticity, but also provides a novel use of this technology across several platforms, most notably in cellular replacement therapies, disease modelling and drug screening. This review will focus on the different ways of implementing TF‐mediated reprogramming, their associated epigenetic changes and its therapeutic potential.
- 1 July 2014
- Published by Elsevier in Differentiation
- Vol. 88 (1) , 29-32
Epigenetic memory in somatic cell nuclear transfer and induced pluripotency: Evidence and implications
- 1 July 2014
- Published by Elsevier in Differentiation
- Vol. 88 (1) , 29-32
Epigenetic memory in somatic cell nuclear transfer and induced pluripotency: Evidence and implications
- 1 June 2014
- Published by Elsevier in Differentiation
- Vol. 87 (5) , 193-199
GM-CSF and MEF-conditioned media support feeder-free reprogramming of mouse granulocytes to iPS cells
- 1 June 2014
- Published by Elsevier in Differentiation
- Vol. 87 (5) , 193-199
GM-CSF and MEF-conditioned media support feeder-free reprogramming of mouse granulocytes to iPS cells